Medtronic shares dip
Medtronic issues recall for MiniMed insulin pumps over battery issues
Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the issue has revealed that the devices may experience shortened battery life if they are dropped,
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life.
Medtronic shares dip after FDA tags insulin pump recall as Class I
Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump.
Medtronic Recalls MiniMed Pump Due To Battery Life Concerns
Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages.
Medtronic Recalls MiniMed 600/700 Series Insulin Pumps For Shortened Battery Life
Medtronic plc, an Irish healthcare technology company, is recalling its MiniMed 600 series or 700 series insulin pumps citing
Medtronic Recalls MiniMed Insulin Pumps Over Battery Issues -- Update
The Dublin-based medical-device maker said Friday that customers of its MiniMed 600 series or 700 series insulin pumps have reported shortened battery life in pumps that have been dropped or experienced some kind of physical impact that damaged internal components.
Is Medtronic plc (NYSE:MDT) The Top Goldman Sachs Fund Manager Stock Pick?
We recently made a list of Goldman Sachs’ Top Fund Manager Stock Picks: 25 Best Overweight Stocks. In this piece, we will ...
Medtronic: This Dividend Aristocrat Is Still A Buy Now
Discover why Medtronic is a top Dividend Aristocrat with strong financial performance and potential for 12% annual returns ...
KSTP-TV16h
St. Paul Art Crawl, Medtronic TC Marathon make for a busy weekend in the Twin Cities
The Medtronic TC Marathon, as well as the St. Paul Art Crawl will be bringing thousands of people to each event.
MassDevice2d
The top 10 neurotech stories of the year so far
Across medtech, companies have continued to innovate through the first nine months of 2024, and that rings especially true in ...
GI Alliance Collaborates with Medtronic to Introduce GI Genius™ AI Technology for Enhanced Colon Polyp Detection
The Medtronic GI Genius™ system demonstrates AI's capacity to improve diagnostic accuracy by serving as a second set of eyes for clinicians, demonstrating 99.7%-100% sensitivity rate when screening ...
GlobalData on MSN5d
Medtronic’s PulseSelect system shows lesion durability in Afib treatment
Medtronic has announced new clinical study results showcasing a high durable lesion formation rate for the PulseSelect pulsed ...
Zacks.com on MSN4d
Reasons to Retain Medtronic Stock in Your Portfolio Now
Medtronic plc’s MDT growth is backed by remarkable progress within the Neurosurgery Portfolio. The company’s continuous ...
Becker's Spine Review4d
Medtronic in Q3: 4 notes
Medtronic leaned into its robotics and navigation strategy during the third quarter of 2024. Here are four things to know: 1. On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff ...